DBT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.537000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.703600E-01
Normal-vs-Stage2
3.575000E-01
Normal-vs-Stage3
1.970490E-02
Normal-vs-Stage4
6.544800E-01
Stage1-vs-Stage2
3.281200E-01
Stage1-vs-Stage3
9.130200E-02
Stage1-vs-Stage4
5.280800E-01
Stage2-vs-Stage3
6.401500E-03
Stage2-vs-Stage4
7.016300E-02
Stage3-vs-Stage4
1.017990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.378200E-01
Normal-vs-AfricanAmerican
8.058400E-01
Normal-vs-Asian
1.965440E-01
Caucasian-vs-AfricanAmerican
3.809800E-01
Caucasian-vs-Asian
3.760800E-01
AfricanAmerican-vs-Asian
2.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.069800E-01
Normal-vs-Female
4.280400E-01
Male-vs-Female
4.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.636600E-01
Normal-vs-Age(41-60Yrs)
5.713800E-01
Normal-vs-Age(61-80Yrs)
2.894600E-01
Normal-vs-Age(81-100Yrs)
2.688000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.798000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.733600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.445000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.995700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.520840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.087800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.001600E-02
Normal-vs-Daily Drinker
1.958410E-01
Normal-vs-Weekly Drinker
1.249390E-01
Normal-vs-Occasional Drinker
7.425400E-01
Normal-vs-Social Drinker
6.766400E-01
Non Drinker-vs-Daily Drinker
7.989400E-01
Non Drinker-vs-Weekly Drinker
9.280600E-01
Non Drinker-vs-Occasional Drinker
2.136300E-02
Non Drinker-vs-Social Drinker
4.275600E-02
Daily Drinker-vs-Weekly Drinker
7.920800E-01
Daily Drinker-vs-Occasional Drinker
8.699800E-02
Daily Drinker-vs-Social Drinker
1.396640E-01
Weekly Drinker-vs-Occasional Drinker
7.199500E-02
Weekly Drinker-vs-Social Drinker
1.090760E-01
Occasional Drinker-vs-Social Drinker
8.772000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.442600E-01
Normal-vs-Grade 2
7.216200E-02
Normal-vs-Grade 3
8.150100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.773380E-01
Grade 1-vs-Grade 3
2.241400E-01
Grade 1-vs-Grade 4
2.442600E-01
Grade 2-vs-Grade 3
9.494200E-01
Grade 2-vs-Grade 4
7.216200E-02
Grade 3-vs-Grade 4
8.150100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.285000E-01
Normal-vs-NonDiabetic
2.290400E-01
Diabetic-vs-NonDiabetic
6.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.600640E-01
Normal-vs-NoPancreatitis
2.633400E-01
Pancreatitis-vs-NoPancreatitis
7.150000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.399600E-01
Normal-vs-N1
3.936200E-01
N0-vs-N1
4.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.534600E-01
Normal-vs-TP53-NonMutant
6.401600E-01
TP53-Mutant-vs-TP53-NonMutant
3.027200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
